Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MEYLAN

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neurovirology|May 13, 1999
Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous systemA Iten, P Chatelard, P Vuadens, et al.
Transplantation|November 25, 2010
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipientsNoémie Boillat Blanco, Manuel Pascual, Jean-Pierre Venetz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 19, 2007
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiencyO Manuel, P E Tarr, J-P Venetz, et al.
AIDS Research and Human Retroviruses|August 1, 1990
Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virusR S Kornbluth, J R Munis, P S Oh, et al.
Ocular Immunology and Inflammation|December 28, 1999
Detection of CMV DNA in peripheral blood leukocytes as a long-range harbinger of CMV disease in HIV-infected patients. Swiss HIV Cohort StudyK R Jaton, C R Muheim, M T Barbani, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidityN Künzle, C Petignat, P Francioli, et al.
Clinical Transplantation|January 29, 2010
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective studyOriol Manuel, Manuel Pascual, Nancy Perrottet, et al.
Swiss Medical Weekly|December 7, 2007
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantationOriol Manuel, Jean-Pierre Venetz, Jacques Fellay, et al.
AIDS (London, England)|March 9, 2000
CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapyF J Torriani, W R Freeman, J C Macdonald, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 8, 2011
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipientsOriol Manuel, Atul Humar, Carine Berutto, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neurovirology|May 13, 1999
Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous systemA Iten, P Chatelard, P Vuadens, et al.
Transplantation|November 25, 2010
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipientsNoémie Boillat Blanco, Manuel Pascual, Jean-Pierre Venetz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 19, 2007
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiencyO Manuel, P E Tarr, J-P Venetz, et al.
AIDS Research and Human Retroviruses|August 1, 1990
Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virusR S Kornbluth, J R Munis, P S Oh, et al.
Ocular Immunology and Inflammation|December 28, 1999
Detection of CMV DNA in peripheral blood leukocytes as a long-range harbinger of CMV disease in HIV-infected patients. Swiss HIV Cohort StudyK R Jaton, C R Muheim, M T Barbani, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidityN Künzle, C Petignat, P Francioli, et al.
Clinical Transplantation|January 29, 2010
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective studyOriol Manuel, Manuel Pascual, Nancy Perrottet, et al.
Swiss Medical Weekly|December 7, 2007
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantationOriol Manuel, Jean-Pierre Venetz, Jacques Fellay, et al.
AIDS (London, England)|March 9, 2000
CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapyF J Torriani, W R Freeman, J C Macdonald, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 8, 2011
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipientsOriol Manuel, Atul Humar, Carine Berutto, et al.
Pageof 5